As expected, sales growth was challenged in the second quarter of 2009. The
global recession and a US bioethanol industry under pressure impacted
Novozymes' sales growth negatively. Sales in the first half were up by 3% in
DKK and down by 3% in local currency (LCY). Operating profit increased by 7%,
raising operating profit margin to 19.3%. Expected 2009 sales growth in LCY is
maintained at slightly positive. Full-year expectations for operating and net
profit growth are also maintained, whereas the full-year free cash flow
expectation is increased due to a lower investment level. 

Download the full statement